Compound Heterozygosity for Loss-of-function FARSB Variants in a Patient with Classic Features of Recessive Aminoacyl-tRNA Synthetase-related Disease

Overview

Journal Hum Mutat

Specialty Genetics

Date 2018 Mar 25

PMID 29573043

Citations 24

Authors

Anthony Antonellis

Stephanie N Oprescu

Laurie B Griffin

Amer Heider

Andrea Amalfitano

Jeffrey W Innis

Affiliations

Soon will be listed here.

Abstract

Aminoacyl-tRNA synthetases (ARSs) are ubiquitously expressed enzymes that ligate amino acids onto tRNA molecules. Genes encoding ARSs have been implicated in phenotypically diverse dominant and recessive human diseases. The charging of tRNA with phenylalanine is performed by a tetrameric enzyme that contains two alpha (FARSA) and two beta (FARSB) subunits. To date, mutations in the genes encoding these subunits (FARSA and FARSB) have not been implicated in any human disease. Here, we describe a patient with a severe, lethal, multisystem, developmental phenotype who was compound heterozygous for FARSB variants: p.Thr256Met and p.His496Lysfs*14. Expression studies using fibroblasts isolated from the proband revealed a severe depletion of both FARSB and FARSA protein levels. These data indicate that the FARSB variants destabilize total phenylalanyl-tRNA synthetase levels, thus causing a loss-of-function effect. Importantly, our patient shows strong phenotypic overlap with patients that have recessive diseases associated with other ARS loci; these observations strongly support the pathogenicity of the identified FARSB variants and are consistent with the essential function of phenylalanyl-tRNA synthetase in human cells. In sum, our clinical, genetic, and functional analyses revealed the first FARSB variants associated with a human disease phenotype and expand the locus heterogeneity of ARS-related human disease.

Citing Articles

Setting the Stage for Treatment of Aminoacyl-tRNA Synthetase (ARS)1-Deficiencies: Phenotypic Characterization and a Review of Treatment Effects.

Hoytema van Konijnenburg E, Rohof J, Kok G, van Hasselt P, van Karnebeek C, Muffels I J Inherit Metab Dis. 2025; 48(2):e70017.

PMID: 40044141 PMC: 11882346. DOI: 10.1002/jimd.70017.

Loss-of-Function CARS1 Variants in a Patient With Microcephaly, Developmental Delay, and a Brittle Hair Phenotype.

Del Greco C, Kuo M, Smith D, Mendes M, Salamons G, Nemcovic M Mol Genet Genomic Med. 2025; 13(2):e70078.

PMID: 39963003 PMC: 11833167. DOI: 10.1002/mgg3.70078.

Simultaneous determination of cytosolic aminoacyl-tRNA synthetase activities by LC-MS/MS.

Mendes M, Wolf N, Rudinger-Thirion J, Lenz D, Frugier M, Verloo P Nucleic Acids Res. 2024; 52(22):e107.

PMID: 39574415 PMC: 11662674. DOI: 10.1093/nar/gkae1134.

Aminoacyl-tRNA synthetase defects in neurological diseases.

Zhang H, Ling J IUBMB Life. 2024; 77(1):e2924.

PMID: 39487674 PMC: 11611227. DOI: 10.1002/iub.2924.

Assessing TGF-β Prognostic Model Predictions for Chemotherapy Response and Oncogenic Role of FKBP1A in Liver Cancer.

Chen W, Que Q, Zhong R, Lin Z, Yi Q, Wang Q Curr Pharm Des. 2024; 30(39):3131-3152.

PMID: 39185649 DOI: 10.2174/0113816128326151240820105525.

References

Walker M, Mohler K, Hopkins K, Oakley D, Sweetser D, Ibba M . Novel Compound Heterozygous Mutations Expand the Recognized Phenotypes of FARS2-Linked Disease. J Child Neurol. 2016; 31(9):1127-37. PMC: 4981184. DOI: 10.1177/0883073816643402. View

Almalki A, Alston C, Parker A, Simonic I, Mehta S, He L . Mutation of the human mitochondrial phenylalanine-tRNA synthetase causes infantile-onset epilepsy and cytochrome c oxidase deficiency. Biochim Biophys Acta. 2013; 1842(1):56-64. PMC: 3898479. DOI: 10.1016/j.bbadis.2013.10.008. View

Finarov I, Moor N, Kessler N, Klipcan L, Safro M . Structure of human cytosolic phenylalanyl-tRNA synthetase: evidence for kingdom-specific design of the active sites and tRNA binding patterns. Structure. 2010; 18(3):343-53. DOI: 10.1016/j.str.2010.01.002. View

Cho J, Kim S, Kim H, Chung T, Kim D, Jang S . FARS2 mutation and epilepsy: Possible link with early-onset epileptic encephalopathy. Epilepsy Res. 2017; 129:118-124. DOI: 10.1016/j.eplepsyres.2016.11.022. View

Vester A, Velez-Ruiz G, McLaughlin H, Lupski J, Talbot K, Vance J . A loss-of-function variant in the human histidyl-tRNA synthetase (HARS) gene is neurotoxic in vivo. Hum Mutat. 2012; 34(1):191-9. PMC: 3535524. DOI: 10.1002/humu.22210. View

Guo F, Cavener D . The GCN2 eIF2alpha kinase regulates fatty-acid homeostasis in the liver during deprivation of an essential amino acid. Cell Metab. 2007; 5(2):103-14. DOI: 10.1016/j.cmet.2007.01.001. View

Sasaki H, Sekine S, Sengoku T, Fukunaga R, Hattori M, Utsunomiya Y . Structural and mutational studies of the amino acid-editing domain from archaeal/eukaryal phenylalanyl-tRNA synthetase. Proc Natl Acad Sci U S A. 2006; 103(40):14744-9. PMC: 1595422. DOI: 10.1073/pnas.0603182103. View

Scheper G, van der Knaap M, Proud C . Translation matters: protein synthesis defects in inherited disease. Nat Rev Genet. 2007; 8(9):711-23. DOI: 10.1038/nrg2142. View

Nowaczyk M, Huang L, Tarnopolsky M, Schwartzentruber J, Majewski J, Bulman D . A novel multisystem disease associated with recessive mutations in the tyrosyl-tRNA synthetase (YARS) gene. Am J Med Genet A. 2016; 173(1):126-134. DOI: 10.1002/ajmg.a.37973. View

10.

Vernon H, McClellan R, Batista D, Naidu S . Mutations in FARS2 and non-fatal mitochondrial dysfunction in two siblings. Am J Med Genet A. 2015; 167A(5):1147-51. DOI: 10.1002/ajmg.a.36993. View

11.

Raina M, Moghal A, Kano A, Jerums M, Schnier P, Luo S . Reduced amino acid specificity of mammalian tyrosyl-tRNA synthetase is associated with elevated mistranslation of Tyr codons. J Biol Chem. 2014; 289(25):17780-90. PMC: 4067211. DOI: 10.1074/jbc.M114.564609. View

12.

Cheng J, Randall A, Baldi P . Prediction of protein stability changes for single-site mutations using support vector machines. Proteins. 2005; 62(4):1125-32. DOI: 10.1002/prot.20810. View

13.

Raviglione F, Conte G, Ghezzi D, Parazzini C, Righini A, Vergaro R . Clinical findings in a patient with FARS2 mutations and early-infantile-encephalopathy with epilepsy. Am J Med Genet A. 2016; 170(11):3004-3007. DOI: 10.1002/ajmg.a.37836. View

14.

Adzhubei I, Schmidt S, Peshkin L, Ramensky V, Gerasimova A, Bork P . A method and server for predicting damaging missense mutations. Nat Methods. 2010; 7(4):248-9. PMC: 2855889. DOI: 10.1038/nmeth0410-248. View

15.

Valente L, Tiranti V, Marsano R, Malfatti E, Fernandez-Vizarra E, Donnini C . Infantile encephalopathy and defective mitochondrial DNA translation in patients with mutations of mitochondrial elongation factors EFG1 and EFTu. Am J Hum Genet. 2006; 80(1):44-58. PMC: 1785320. DOI: 10.1086/510559. View

16.

Lek M, Karczewski K, Minikel E, Samocha K, Banks E, Fennell T . Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016; 536(7616):285-91. PMC: 5018207. DOI: 10.1038/nature19057. View

17.

Delepine M, Nicolino M, Barrett T, Golamaully M, Lathrop G, Julier C . EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome. Nat Genet. 2000; 25(4):406-9. DOI: 10.1038/78085. View

18.

van Meel E, Wegner D, Cliften P, Willing M, White F, Kornfeld S . Rare recessive loss-of-function methionyl-tRNA synthetase mutations presenting as a multi-organ phenotype. BMC Med Genet. 2013; 14:106. PMC: 3852179. DOI: 10.1186/1471-2350-14-106. View

19.

Shamseldin H, Alshammari M, Al-Sheddi T, Salih M, Alkhalidi H, Kentab A . Genomic analysis of mitochondrial diseases in a consanguineous population reveals novel candidate disease genes. J Med Genet. 2012; 49(4):234-41. DOI: 10.1136/jmedgenet-2012-100836. View

20.

Yang Y, Liu W, Fang Z, Shi J, Che F, He C . A Newly Identified Missense Mutation in FARS2 Causes Autosomal-Recessive Spastic Paraplegia. Hum Mutat. 2015; 37(2):165-9. DOI: 10.1002/humu.22930. View